| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $162K | — | -0.9% |
| Cost of Revenue | $86K | — | +17.0% |
| Gross Profit | $76K | — | -15.4% |
| R&D Expense | $281K | — | -30.9% |
| SG&A Expense | $1.9M | — | +12.1% |
| Operating Income | -$2.1M | — | -9.6% |
| Pre-tax Income | -$2.1M | — | -11.3% |
| Net Income | -$2.1M | — | -11.3% |
| EPS (Basic) | -$1.28 | — | +17.9% |
| EPS (Diluted) | -$1.28 | — | +17.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.3M | +121.0% | -3.3% |
| Short-term Investments | $1.2M | +0.0% | — |
| Accounts Receivable | $336K | -34.1% | -31.2% |
| Inventory | $911K | +38.6% | +17.8% |
| Current Assets | $6.3M | +27.9% | +10.8% |
| Total Assets | $6.8M | +26.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | -71.6% |
| Capital Expenditures | $30K | — | +1020.2% |
| Investing Cash Flow | $1.2M | — | -29.9% |
| Financing Cash Flow | $3.4M | — | +98.6% |
| Free Cash Flow | -$2.8M | — | -73.2% |
| +13.1% |
| Current Liabilities | $1.9M | +1.8% | +4.1% |
| Long-term Debt | $150K | +0.0% | +0.0% |
| Total Liabilities | $2.0M | +1.6% | +3.6% |
| Stockholders' Equity | $4.8M | +39.4% | +17.5% |